MeSH D002481 - cellulitis
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Teva | Cloxacillin | Cloxacillin | 1982-01-01 | |||
| Oxacillin | Oxacillin | 1982-01-01 | ||||
| GSK | Oxacillin | Bactocill | 1982-01-01 | |||
| Cloxacillin | Cloxapen | 1982-01-01 | ||||
| Nafcillin | Nallpen | 1982-01-01 | ||||
| Sandoz | Nafcillin | Nafcillin | 1984-08-02 | |||
| Oxacillin | Oxacillin | 1982-01-01 | ||||
| Wyeth | Nafcillin | Unipen | 1986-12-16 | |||
| Hospira | Aztreonam | Aztreonam | 2021-11-08 | |||
| Oxacillin | Oxacillin | 2015-12-11 | ||||
| Wockhardt | Oxacillin | Oxacillin | 2017-07-31 | |||
| Bristol Myers Squibb | Aztreonam | Azactam | 1986-12-31 | |||
| Cloxacillin | Cloxacillin | 1982-01-01 | ||||
| Nafcillin | Nafcillin | 1982-01-01 | ||||
| Oxacillin | Oxacillin | 1982-01-01 | ||||
| Oxacillin | Prostaphlin | 1982-01-01 | ||||
| Cloxacillin | Tegopen | 1982-01-01 | ||||
| ANI Pharmaceuticals | Oxacillin | Oxacillin | 1982-01-01 |
1
2
3
>
Clinical Trials
Historical Success Rate
Phase 1
0%0/0
Phase 2
58%7/12
Phase 3
30%6/20
Approved: 5Overall Success rate: 0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
1
2
>
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use